세계의 의료용 면봉(스왑) 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 용도별, 유형별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Medical Swab Market Growth & Trends:

The global medical swab market size is anticipated to reach USD 813.3 million by 2030, growing at a CAGR of 4.9% during the forecast period, according to a new report by Grand View Research, Inc. The medical swab industry is experiencing significant growth due to the increasing prevalence of infectious diseases, coupled with the growing burden of chronic conditions and an increasing focus on preventative healthcare measures, has resulted in a substantial surge in demand for diagnostic testing. As medical swabs are essential for specimen collection across a range of diagnostic procedures, including polymerase chain reaction (PCR) assays, rapid antigen tests, and microbiological cultures, this rise in global diagnostic testing directly translates into heightened demand for medical swabs, thus driving market growth.

Innovations in diagnostic technologies, such as point-of-care testing and rapid antigen tests, have further propelled the demand for medical swabs. These advanced diagnostic methods often rely on swabs for sample collection, enabling faster and more accurate diagnoses. As technology continues to advance, the medical swab industry is expected to witness further growth, driven by the increasing need for efficient and reliable sample collection tools.

The increasing adoption of at-home diagnostic testing, driven by its inherent convenience and accessibility, has become a significant factor in the market's expansion. The growing preference for self-administered tests across a range of health conditions, including respiratory illnesses, pregnancy, and substance abuse monitoring, has directly correlated with a substantial increase in demand for medical swabs designed for self-collection, thereby contributing significantly to overall market growth.

According to the National Institute on Drug Abuse (NIDA), workplace drug testing continues to expand as employers recognize the importance of maintaining a drug-free environment. This trend is especially evident in safety-sensitive jobs where impairment could result in accidents. As a result, the medical swabs market is benefiting from the increasing implementation of drug testing programs.

Medical Swab Market Report Highlights:

• Based on product, the cotton-tipped swabs dominated the industry with the largest revenue share in 2024, owing to their versatility, cost-effectiveness, and widespread use in diagnostic, sampling, and drug testing applications.
• Based on type, the specimen collection dominated the industry with the largest revenue share as swabs are essential for efficiently obtaining samples for diagnostic testing, including infections, drug testing, and genetic analysis.
• Based on application, the nasopharyngeal (NP) swabs dominated the industry with the largest revenue share owing to their critical role in collecting samples for accurate respiratory disease diagnosis, including COVID-19 testing.
• Based on end use, the hospitals & clinics dominated the industry with the largest revenue share as primary healthcare settings where swabs are extensively used for diagnostic testing, infection control, and patient monitoring.
• North America dominated the medical swab industry with a share of 30.87% in 2024. This can be attributed to advanced healthcare infrastructure, high demand for diagnostic testing, and the widespread adoption of medical technologies.

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical Swab Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Demand for Diagnostic Testing
    • 3.2.1.2. Rising Prevalence of Infectious Diseases
    • 3.2.1.3. Growing Popularity of Home Testing
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited Awareness in Developing Regions
• 3.3. Medical Swab Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Medical Swab Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Medical Swab Market Product Movement Analysis
• 4.3. Medical Swab Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Cotton-tipped Swabs
  • 4.4.1. Cotton-tipped Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Foam-tipped Swabs
  • 4.5.1. Foam-tipped Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Medical Swab Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Medical Swab Market Application Movement Analysis
• 5.3. Medical Swab Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Specimen Collection
  • 5.4.1. Specimen Collection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Microbiological Testing
  • 5.5.1. Microbiological Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Diagnostic Procedures
  • 5.6.1. Diagnostic Procedures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Wound Care
  • 5.7.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Dental Care
  • 5.8.1. Dental Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Medical Swab Market: Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Medical Swab Market Type Movement Analysis
• 6.3. Medical Swab Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 6.4. Nasopharyngeal (NP) Swabs
  • 6.4.1. Nasopharyngeal (NP) Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Nasal Swabs
  • 6.5.1. Nasal Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Oral Swabs
  • 6.6.1. Oral Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Wound Swabs
  • 6.7.1. Wound Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Vaginal Swabs
  • 6.8.1. Vaginal Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Medical Swab Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Medical Swab Market End Use Movement Analysis
• 7.3. Medical Swab Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Laboratories & Diagnostic Centers
  • 7.5.1. Laboratories & Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Home Test
  • 7.6.1. Home Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Medical Swab Market: Regional Estimates & Trend Analysis By Type, By End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. North America Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Scenario
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. U.S. Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Scenario
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Canada Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Scenario
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. Mexico Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Scenario
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. UK Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Scenario
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. Germany Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Scenario
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. France Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Scenario
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Italy Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Scenario
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. Spain Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Scenario
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Denmark Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Scenario
    • 8.4.8.4. Reimbursement Scenario
    • 8.4.8.5. Sweden Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Scenario
    • 8.4.9.4. Reimbursement Scenario
    • 8.4.9.5. Norway Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Scenario
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Japan Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Scenario
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. China Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Scenario
    • 8.5.4.4. Reimbursement Scenario
    • 8.5.4.5. India Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Scenario
    • 8.5.5.4. Reimbursement Scenario
    • 8.5.5.5. South Korea Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Scenario
    • 8.5.6.4. Reimbursement Scenario
    • 8.5.6.5. Australia Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Scenario
    • 8.5.7.4. Reimbursement Scenario
    • 8.5.7.5. Thailand Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Scenario
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Brazil Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Scenario
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Argentina Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Scenario
    • 8.7.2.4. Reimbursement Scenario
    • 8.7.2.5. South Africa Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Scenario
    • 8.7.3.4. Reimbursement Scenario
    • 8.7.3.5. Saudi Arabia Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Scenario
    • 8.7.4.4. Reimbursement Scenario
    • 8.7.4.5. UAE Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Scenario
    • 8.7.5.4. Reimbursement Scenario
    • 8.7.5.5. Kuwait Medical Swab Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Copan Diagnostics Inc.
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Service Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. Dynarex Corporation
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Service Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. GPC Medical Ltd.
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Service Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. Puritan Medical Products
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Service Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. BD
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Service Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. AdvaCare Pharma
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Service Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Medline Industries, LP.
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Service Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. Cardinal Health
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Service Benchmarking
    • 9.2.8.4. Strategic Initiatives